Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward.
Xiudi HanXiao-Pu HeYimin WangHui LiHong WangXiqian XingChunxiao ZhangLijun SuoJinxiang WangGuohua YuGuangqiang WangXuexin YaoHongxia YuLei WangXuedong LiuBin Caonull nullPublished in: Infection and drug resistance (2021)
Non-inferiority of clinical failure occurrence and short-term mortality was observed in different guideline-concordant antimicrobial regimens for elderly patients with CAP in general wards; however, the median LOS and hospitalization-associated costs for one elderly CAP episode with fluoroquinolone monotherapy were significantly lowest, and this strategy was considered to be the most cost-effective strategy in general wards.
Keyphrases
- middle aged
- community acquired pneumonia
- community dwelling
- end stage renal disease
- staphylococcus aureus
- newly diagnosed
- ejection fraction
- chronic kidney disease
- risk assessment
- prognostic factors
- type diabetes
- clinical trial
- cardiovascular disease
- patient reported outcomes
- combination therapy
- coronary artery disease